Form 8-K Hims & Hers Health, Inc. For: May 11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
BTIG on Hims and Hers (HIMS): 'will need to aggressively manage sales and marketing costs'
May 12, 2026 7:51 AM EDTBTIG analyst David Larsen reiterated a Neutral rating on Hims and Hers (NYSE: HIMS).
The analyst comments "On Monday 5/11/26, AMC HIMS reported 1Q:26 results. Revenue of $608M +3.8% y/y was behind BTIG / consensus of $620.1M / $617M, and adjusted EBITDA of $44.3M -51% y/y was also well behind BTIG / consensus of $49.6M / $47M. Despite the top-line miss, full-year 2026... More
